PI2620, CBD2115, and PM-PBB3 all showedhigher binding affinities to CBD tau than the 3R/4R tracer MK6240.The same strategy has also been applied to AD tau fibrils, and significantdifferences in selectivity of binding sites were also observed. Here, MAPT is linked to Alzheimer disease.